Copyright
©The Author(s) 2024.
World J Gastroenterol. Aug 14, 2024; 30(30): 3564-3573
Published online Aug 14, 2024. doi: 10.3748/wjg.v30.i30.3564
Published online Aug 14, 2024. doi: 10.3748/wjg.v30.i30.3564
Figure 2 Waterfall plot of the best response of the patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma, as per response evaluation criteria in solid tumors (RECIST 1.
1).
- Citation: Xu LX, Yuan JJ, Xue R, Zhou J. Nab-paclitaxel plus capecitabine as first-line treatment for advanced biliary tract cancers: An open-label, non-randomized, phase II clinical trial. World J Gastroenterol 2024; 30(30): 3564-3573
- URL: https://www.wjgnet.com/1007-9327/full/v30/i30/3564.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i30.3564